等待开盘 11-26 09:30:00 美东时间
-0.030
-0.21%
Fluence Corporation Limited ( ($AU:FLC) ) has provided an announcement. Fluence...
今天 07:07
Oracle expands Abu Dhabi cloud region with Middle East's first Nvidia-powered OCI Supercluster, supporting sovereign AI initiatives and strengthening UAE's position as regional AI hub.
11-25 23:42
Ondas Holdings ( ($ONDS) ) has issued an update. On November 23, 2025, Ondas Ho...
11-25 22:48
Ondas (ONDS) is set to acquire Robo-Team Holdings, a global developer of rugged tactical unmanned ground vehicles. Financial terms of the transaction were not disclosed. The Boston, MA-based autonomou...
11-25 22:00
MIAMI, Nov. 25, 2025 /PRNewswire/ -- Trax, the preeminent global provider of paperless aviation maintenance and engineering software products, announced that Pan Am, one of the most iconic b...
11-25 21:30
三大指数集体上涨,恒指涨近0.7%,科指涨1.2%;科网股普涨,哔哩哔哩涨超5%,百度、小米涨超4%,阿里巴巴涨超2%,即将公布业绩;有色金属板块涨幅居前,天齐锂业涨超4%>>
11-25 16:15
- UNICEPTA, a global media intelligence provider within The Marketing Cloud, part of Stagwell (NASDAQ:STGW), today announced the launch of an integration with Microsoft 365 Copilot to make its reputation and media
11-25 16:06
The Columbus Crew and ScottsMiracle-Gro Company have expanded their partnership, with the latter securing naming rights to the Crew's downtown stadium, now to be called ScottsMiracle-Gro Field starting in 2026. The agreement also includes community initiatives focused on youth soccer and outdoor activities. The stadium, which opened in 2021, has already hosted major events and will continue to serve as a centerpiece for Astor Park, a mixed-use do...
11-25 14:15
Akari Therapeutics announced the publication of its latest CEO Corner segment, where CEO Abizer Gaslightwala highlights the company's innovation in antibody drug conjugates (ADCs), particularly its novel PH1 payload with a dual mechanism of action. He also discusses Akari's next-generation ADC discovery platform and its mission to develop differentiated therapies for patients. The PH1 payload, a spliceosome modulator, disrupts RNA splicing in can...
11-25 14:00
Palisade Bio, Inc. announced its CEO and Chief Medical Officer will participate in a fireside chat at Piper Sandler's 37th Annual Healthcare Conference on December 4, 2025. The event will be live streamed and replayed for accessibility. Palisade Bio is advancing a PDE4 inhibitor prodrug, PALI-2108, showing promising results in Phase 1b trials for Ulcerative Colitis and Fibrostenotic Crohn’s Disease, with plans for further Phase 2 studies. The com...
11-25 13:45